Monday, June 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Investors Guide What to Expect from Cronos Groups Latest Earnings Report

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

Cronos Group, a leading company in the cannabis industry, is set to reveal its latest quarterly earnings report on February 29, 2024. Here are some key points for investors to keep in mind ahead of the announcement:

– Analysts are estimating that Cronos Group will report an EPS of $-0.01 for this quarter.
– While meeting or exceeding earnings estimates can impact stock prices, investors should pay close attention to the guidance and forecasted growth for the upcoming quarter.
– In the previous quarter, Cronos Group surpassed EPS expectations by $0.02, resulting in a 1.5% decrease in share price the following day.
– Looking back at past performance, Cronos Group has experienced fluctuations in EPS and corresponding price changes in recent quarters.

For the most up-to-date information on Cronos Group’s earnings, investors are encouraged to stay informed through financial news sources and the company’s official announcements.

CRON Stock Price Rises 2.68% on February 28, 2024: Investors Eye Positive Momentum

On February 28, 2024, CRON stock closed at $2.30, marking a $0.06 increase from the previous market close, representing a 2.68% rise in the stock price for the day. However, the stock did experience a slight drop of $0.01 in after-hours trading.

CRON is currently trading in the middle of its 52-week range and is above its 200-day simple moving average, indicating relative stability and strength in its price trend over a longer period of time.

Investors may be keeping an eye on CRON as it continues to show positive price momentum. The stock’s performance on February 28, 2024, suggests bullish sentiment surrounding the company. It is important for investors to conduct their own research and analysis before making any investment decisions.

Overall, CRON’s performance on February 28, 2024, demonstrates some positive movement in the stock price. Investors should stay informed about the company’s financials, market trends, and any other relevant factors that may impact the stock’s performance in the future.

Cronos Group Inc. Reports Significant Revenue Growth in 2024: Financial Performance Overview

On February 28, 2024, Cronos Group Inc. (CRON) saw a significant increase in its total revenue compared to the previous year and quarter. According to data from CNN Money, the company reported a total revenue of $91.90 million for the past year, which marks a 23.47% increase from the previous year. In the most recent quarter, Cronos Group reported a total revenue of $24.81 million, showing a 30.43% increase from the previous quarter.

Furthermore, Cronos Group also saw improvements in its net income figures. The company reported a net income of -$168.73 million for the past year, which represents a 57.4% increase from the previous year. In the most recent quarter, Cronos Group reported a net income of -$1.46 million, showing a 73.54% increase from the previous quarter.

Additionally, the earnings per share (EPS) for Cronos Group also showed positive growth. The company reported an EPS of -$0.45 for the past year, marking a 58.14% increase from the previous year. In the most recent quarter, Cronos Group reported an EPS of -$0.00, showing a 79.53% increase from the previous quarter.

Overall, Cronos Group’s financial performance on February 28, 2024, reflected positive growth in total revenue, net income, and earnings per share compared to the previous year and quarter. Investors and analysts may view these improvements as a sign of the company’s financial health and potential for future growth.

Tags: CRON
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Investing in stocks

Mizuho Analyst Maintains Neutral Rating on Sealed Air with Lowered Price Target

Financial literacy and school

Analyst Reiterates Buy Rating on Staar Surgical with Lower Price Target

Technology Artificial intelligence Markets and money

C3 AI Reports Strong Financial Results and Industry Expansion in Q3 Fiscal 2024

Recommended

Api Corp Stock

APi Group Stock Navigates Strong Earnings and Shifting Investor Sentiment

9 months ago
Fastenal Stock

Fastenal Stock Seeks Momentum Amid Market Skepticism

7 months ago
Gold Stock

Gold’s Calm Before the Storm: A Brewing Breakout?

7 months ago
Lvmh Moet Hennessy Louis Vuitton Adr Stock

LVMH Navigates Shifting Tides in the Global Luxury Market

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nvidia’s CEO Calls the Dip a ‘Discount’ as New PC Chip Takes Aim at Apple’s Turf

Bayer’s Technical Battle at the 200-Day Line Gets Reinforcement from Agriculture AI and Kidney Drug Progress

Dividend-Heavy VanEck ETF Puts Its Money on Financials and Energy as Europe Dominates the Portfolio

Siemens Energy: AI Data Centers Propel Record Backlog, but Profit-Taking Mutes Buyback Impact

German Union Boss Demands Mandatory Company Pensions as Political Rifts Widen

D-Wave Quantum: A Fortune 100 Bet and a University Sale — But the Stock’s Next Move Hinges on a Cent-Wide Support Line

Trending

SpaceX Stock
Newsletter

Apple’s AI Pivot: From Data Center Costs to Consumer Dollars

by Stephanie Dugan
June 8, 2026
0

Dear readers, On Thursday we wrote that the entire high-multiple tech complex — hardware and software alike...

AMD Stock

AMD Stock: Short Interest Jumps 24% as Fundamentals and Analyst Targets Collide After Sector Rout

June 8, 2026
Palantir Stock

New Cloud and Construction Clients Can’t Lift Palantir Past the 50-Day Line

June 8, 2026
Nvidia Stock

Nvidia’s CEO Calls the Dip a ‘Discount’ as New PC Chip Takes Aim at Apple’s Turf

June 8, 2026
Bayer Stock

Bayer’s Technical Battle at the 200-Day Line Gets Reinforcement from Agriculture AI and Kidney Drug Progress

June 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Apple’s AI Pivot: From Data Center Costs to Consumer Dollars
  • AMD Stock: Short Interest Jumps 24% as Fundamentals and Analyst Targets Collide After Sector Rout
  • New Cloud and Construction Clients Can’t Lift Palantir Past the 50-Day Line

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com